Mizuho Maintains Neutral on Doximity, Lowers Price Target to $26

Doximity, Inc. Class A

Doximity, Inc. Class A

DOCS

0.00

Mizuho analyst Steven Valiquette maintains Doximity (NYSE: DOCS) with a Neutral and lowers the price target from $34 to $26.